Apex Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-12-2024
- Paid Up Capital ₹ 0.35 M
as on 30-12-2024
- Company Age 28 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.80 M
as on 30-12-2024
- Revenue 33.44%
(FY 2022)
- Profit 117.88%
(FY 2022)
- Ebitda -1.82%
(FY 2022)
- Net Worth 2.14%
(FY 2022)
- Total Assets 3.60%
(FY 2022)
About Apex Medical Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.35 M.
The company currently has active open charges totaling ₹4.80 M.
Sanjay Chadha and Praveen Sharma serve as directors at the Company.
- CIN/LLPIN
U51397DL1996PTC080708
- Company No.
080708
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Apex Medical Systems Private Limited offer?
Apex Medical Systems Private Limited offers a wide range of products and services, including Used Machinery & Tools, Refurbished Medical Equipment, Diagnostic Medical Imaging Equipment, CT Scan Machine, Electrodiagnostic Instruments, Dental X Ray Machine, Ultrasound Machines, Doppler Machine, MRI Machine, Medical Imaging Machine & Accessories.
Who are the key members and board of directors at Apex Medical Systems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Sharma  | Director | 26-Jul-1996 | Current |
| Sanjay Chadha | Director | 26-Jul-1996 | Current |
Financial Performance of Apex Medical Systems.
Apex Medical Systems Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.44% increase. The company also saw a substantial improvement in profitability, with a 117.88% increase in profit. The company's net worth moved up by a moderate rise of 2.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Medical Systems?
In 2020, Apex Medical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Home Finance Company Limited Creation Date: 29 Oct 2005 | ₹4.80 M | Open |
How Many Employees Work at Apex Medical Systems?
Unlock and access historical data on people associated with Apex Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
